We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+37.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$1.51B
Cap. Flow
+$1.75B
Cap. Flow %
64.98%
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$80.3M
2
BSX icon
Boston Scientific
BSX
+$76.6M
3
KEY icon
KeyCorp
KEY
+$62.3M
4
GS icon
Goldman Sachs
GS
+$60.3M
5
MMED
MiniMed Group Inc
MMED
+$52.4M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$40.7M
2
BDX icon
Becton Dickinson
BDX
+$25.5M
3
TPG icon
TPG
TPG
+$23.9M
4
NVO
Novo Nordisk
NVO
+$22.6M
5
EW icon
Edwards Lifesciences
EW
+$22.1M

Sector Composition

Rank Sector Weight
1 Financials 31.18%
2 Healthcare 16.78%
3 Technology 12.09%
4 Industrials 6.84%
5 Consumer Discretionary 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WERN icon
126
Werner Enterprises
WERN
$2.54B
$3.93M 0.15%
+133,683
New +$4.33M
VNET
127
VNET Group
VNET
$2.05B
$3.6M 0.13%
+429,542
New +$4.55M
UNP icon
128
Union Pacific
UNP
$183B
$3.58M 0.13%
+14,771
New +$3.62M
SHAK icon
129
Shake Shack
SHAK
$2.3B
$3.5M 0.13%
39,530
-2,970
-7% -$273K
FPS
130
Forgent Power Solutions
FPS
$9.33B
$3.47M 0.13%
+118,411
New +$3.94M
ANNX icon
131
Annexon
ANNX
$855M
$3.44M 0.13%
620,401
-2,479,599
-80% -$14M
HUBB icon
132
Hubbell
HUBB
$25.7B
$3.13M 0.12%
+6,371
New +$3.13M
AEO icon
133
American Eagle Outfitters
AEO
$2.85B
$3.06M 0.11%
+183,443
New +$4.12M
EQPT
134
EquipmentShare.com Inc
EQPT
$4.89B
$3.06M 0.11%
+149,976
New +$4.29M
RAL
135
Ralliant Corp
RAL
$7.77B
$3.04M 0.11%
+73,181
New +$3.44M
PLXS icon
136
Plexus
PLXS
$6.81B
$2.9M 0.11%
+14,334
New +$2.72M
BA icon
137
Boeing
BA
$165B
$2.83M 0.1%
+14,234
New +$3.24M
UCTT
138
Ultra Clean Holdings
UCTT
$4.16B
$2.8M 0.1%
+45,004
New +$2.31M
ERAS icon
139
Erasca
ERAS
$6.63B
$2.77M 0.1%
+171,233
New +$2.02M
CGEM icon
140
Cullinan Oncology
CGEM
$1.05B
$2.61M 0.1%
+183,691
New +$2.36M
TRDA icon
141
Entrada Therapeutics
TRDA
$227M
$2.59M 0.1%
+204,978
New +$2.35M
CTMX icon
142
CytomX Therapeutics
CTMX
$705M
$2.58M 0.1%
+550,000
New +$2.79M
CHYM
143
Chime Financial
CHYM
$7.88B
$2.55M 0.09%
136,189
-40,792
-23% -$925K
HLXC
144
Helix Acquisition Corp III
HLXC
$2.51M 0.09%
+247,500
New +$2.53M
ACAAU
145
Averin Capital Acquisition Corp Units
ACAAU
$2.5M 0.09%
+250,000
New +$2.51M
VRT icon
146
Vertiv
VRT
$112B
$2.5M 0.09%
+9,966
New +$2.21M
COST icon
147
Costco
COST
$415B
$2.49M 0.09%
+2,500
New +$2.44M
ALGT icon
148
Allegiant Air
ALGT
$2.64B
$2.37M 0.09%
+29,244
New +$2.69M
BOBS
149
Bobs Discount Furniture
BOBS
$1.97B
$2.35M 0.09%
+200,000
New +$3.41M
CBRL icon
150
Cracker Barrel
CBRL
$1.2B
$2.25M 0.08%
+80,100
New +$2.44M

Similar funds

Longaeva Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Longaeva Partners deployed $1.75B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.

  • Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
  • Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
  • Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
  • Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
  • Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
  • Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.